Starpharma’s Viraleze nasal spray effective against multiple Covid-19 variants
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jun 21
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…
21 Jun 21
EC approved Aubagio as the first oral MS therapy for RRMS, based on data from the Phase 3…
18 Jun 21
Upon closing of the transaction, Aldevron will operate as an individual company and a brand operating within Danaher's…
18 Jun 21
Under the deal, BMS will develop and commercialise the drug in regions outside of the collaboration territories, while…
17 Jun 21
Allcyte’s platform anticipates the activity of cancer treatments using AI to analyse the activity of drugs in live…
17 Jun 21
177Lu-PSMA-617 is an investigational radioligand therapy intended for metastatic castration-resistant prostate cancer (mCRPC)
16 Jun 21
Sage and Biogen claimed that their investigational drug Zuranolone is a potential breakthrough in the management of depression
16 Jun 21
According to the new data, the AstraZeneca Covid-19 vaccine is 92% effective against the Delta variant, and 86%…
15 Jun 21
iTeos will receive an upfront payment of $625m, along with milestone payments of up to $1.45bn, in addition…
15 Jun 21
The Phase 3 PREVENT-19 study also met the key secondary endpoint of 100% efficacy against variants not considered…